Compare ARK Genomic Revolution ETF (ARKG) vs Nu Holdings Ltd (NU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Nu Holdings Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Nu Holdings Ltd trades at $13.71 (market cap $66.47B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Nu Holdings Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | NU | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $18.76 |
52-Week Low | $23.09 | $11.60 |
Market Cap | — | $66.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NU Holdings Ltd. (NU) trades at $13.76, up 0.66% on the day, with a bullish technical signal from moving averages and strong fundamental growth. Revenue grew to $10.63B in 2025 with net income of $2.87B, and the company recently secured authorization for its Mexican banking operations, expanding its Latin American footprint. Analyst consensus is a Buy with a $14.98 price target, though recent quarterly EPS results have missed expectations.
The outlook for NU remains positive due to robust revenue growth and expansion potential, but risks include currency headwinds and competitive pressures. The stock's current valuation at a P/E of 21.22 and P/S of 5.67 reflects its growth trajectory, yet investors should monitor execution risks in new markets and credit portfolio performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →
